ArticleOne health (Amsterdam, Netherlands)2025

Cross-neutralization of human sera with diverse SARS-CoV-2 omicron exposure histories, 2022-2024: Evidence of immune heterogeneity.

Shihan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.